GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AlzeCure Pharma AB (OSTO:ALZCUR) » Definitions » 3-Year EBITDA Growth Rate

AlzeCure Pharma AB (OSTO:ALZCUR) 3-Year EBITDA Growth Rate : 30.90% (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is AlzeCure Pharma AB 3-Year EBITDA Growth Rate?

AlzeCure Pharma AB's EBITDA per Share for the three months ended in Mar. 2024 was kr-0.14.

During the past 3 years, the average EBITDA Per Share Growth Rate was 30.90% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 13.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of AlzeCure Pharma AB was 30.90% per year. The lowest was -46.50% per year. And the median was -3.45% per year.


Competitive Comparison of AlzeCure Pharma AB's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, AlzeCure Pharma AB's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AlzeCure Pharma AB's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AlzeCure Pharma AB's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where AlzeCure Pharma AB's 3-Year EBITDA Growth Rate falls into.



AlzeCure Pharma AB 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


AlzeCure Pharma AB  (OSTO:ALZCUR) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


AlzeCure Pharma AB 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of AlzeCure Pharma AB's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


AlzeCure Pharma AB (OSTO:ALZCUR) Business Description

Traded in Other Exchanges
Address
Halsovagen 7, Novum, Floor 7, Elevator D, Huddinge, SWE, SE 141 57
AlzeCure Pharma AB is a Swedish pharmaceutical company engaged in drug research with a primary focus on Alzheimer's disease. The company develops several drug within its three research platforms NeuroRestore, Alzstatin, Painless.

AlzeCure Pharma AB (OSTO:ALZCUR) Headlines

No Headlines